The Dermatology Innovation Forum has announced its cancellation amid global spread of the coronavirus.
The American Academy of Dermatology Board of Directors has decided to cancel the 2020 Annual Meeting in Denver due to coronavirus concerns.
Sun Dermatology is launching an acne awareness advertising campaign, Take on Acne, that focuses on the skin condition’s impact on teens and young adults’ quality of life.
Introducing The Mainstream Patient, a weekly glimpse into what your patients may be reading in the media about skin health.
Positive phase 3 results from two clinical trials suggests that Sol-Gel’s novel 5% microencapsulated benzoyl peroxide cream may offer quick, effective relief for patients with papulopustular rosacea.
Sun Pharma introduces a lower dose isotretinoin capsule in the U.S. for the treatment of severe recalcitrant nodular acne.
Cosmetic Surgery Forum (CSF) Founder Joel Schlessinger, M.D., Omaha, Neb., sits down with Dermatology Times to give an inside glimpse into the meeting's 11th year.
Dr. Diane Berson spoke with Dermatology Times at ASDS 2019 about her presentation revolving around hormones' effect on hair changes in postmenopausal women.
The link between menopause and aging is one that many patients aren’t aware is affecting them. Speaking with Dermatology Times at ASDS 2019, Dr. Diane Berson highlighted the topic in her presentation on hormones and postmenopausal women.
A combination of ivermectin 1% cream and oral 40-mg doxycycline has the potential to be an effective therapy for some people with moderate to severe rosacea after the publication of results from a phase 3b/4 study examining the combination’s efficacy and safety compared to ivermectin as a monotherapy.